Pathogenic Yersinia (Y. enterocolitica, Y. pseudotuberculosis and Y. pestis) use a syringe-like type III secretion system (T3SS) to inject six Yersinia outer proteins (YopE, YopT, YopH, YopO, YopM and YopJ) into the mammalian host-cell cytosol 7, 8 (Fig. 1) . The Yops act in concert to neutralize the host innate immune response by inhibiting phagocytosis by macrophages and neutrophils and downregulating the inflammatory response 7, 8 .
At least five of the Yops contain eukaryoticlike protein domains, and four (YopE, YopT, YopH and YopO) target the actin cytoskeleton, resulting in rapid actin depolymerization and enhanced virulence of the pathogen. YopE and YopT cause actin depolymerization through effects on Rho family GTPases, which are master regulators of the actin cytoskeleton 9 , whereas the tyrosine phosphatase YopH dephosphorylates focal adhesion kinase (Fak), paxillin and p130 cas , among other targets 7 .
YopO, the largest of the Yops (729 amino acids in Y. enterocolitica, the species studied by Lee et al. 6 ), features an N-terminal membrane-targeting domain (residues 1-89), a serine/threonine kinase domain (residues 108-434) and a C-terminal GDI domain (residues 435-729) (Fig. 1) . Inside the host, YopO is targeted Many bacterial pathogens 1,2 and some viruses 3 use an ever-expanding arsenal of mechanisms to exploit the actin cytoskeleton of host eukaryotic cells for invasion, motility, replication and avoidance of the innate immune response. Several pathogens, including Clostridium botulinum, Salmonella enterica, Photorhabdus luminescens and Vibrio cholerae, secrete toxins that covalently modify actin to either block or promote polymerization 4 . In addition, pathogens such as Listeria monocytogenes, S. enterica and Shigella flexneri, use actin assembly to promote their uptake into eukaryotic cells 5 . Finally, numerous pathogens, including vaccinia virus, L. monocytogenes and Rickettsia spp. have evolved mechanisms to harness the forces of actin polymerization for motility 1 . Elegant work in this issue of Nature Structural & Molecular Biology by Lee et al. 6 sheds light on the mechanism by which pathogenic Yersinia use the antiphagocytic factor YopO (also known as YpkA) to recruit and deactivate actin-assembly factors through phosphorylation. to the plasma membrane via the N-terminal domain 10 . Formation of a 1:1 complex with monomeric actin leads to the autophosphorylation of YopO at Ser90 and Ser95 in the loop between the membrane-targeting and kinase domains, a necessary step in the activation of the kinase 11, 12 .
Because actin is found only in the host, the kinase domain remains inactive inside the pathogen. For its part, the GDI domain inhibits nucleotide exchange on RhoA and Rac1 (but not Cdc42), and disrupting these interactions through mutagenesis results in impaired YopO-induced cytoskeletal effects and in attenuated virulence in vivo 13 . Exogenous expression of YopO in eukaryotic cells produces a major disruption of the actin cytoskeleton [11] [12] [13] [14] [15] . This appears to result from the synergistic action of all the YopO domains, because mutations disabling membrane targeting, Rho GTPase binding or kinase activity result in reduced cytoskeleton disassembly 11, 13, 14, 16 . Although studies using mouse infection models have sometimes produced conflicting results 8 , they have generally supported the notion that YopO has a substantial contribution towards the virulence of Yersinia 13, 14, 17 .
The kinase activity of YopO was discovered more than 20 years ago 17 , yet the mechanism by which it contributes to the neutralization n e w s a n d v i e w s npg Major questions remain about the identity of the cellular substrates of the kinase domain that would explain the effects of YopO on cyto skeleton organization. A major finding by Lee et al. 6 is that, at least in vitro, YopO uses actin not only for activation of the kinase domain but also as bait to recruit and phosphorylate actin-assembly factors that have essential roles in cytoskeleton organization, including VASP family members, the formin mDia1, WASP and gelsolin. Coincidentally, VASP phosphorylation by YopO was recently observed in cells 20 , thus supporting the notion that cytoskeletal proteins are likely to emerge as the primary targets of YopO's kinase activity. Whether such phosphorylation actually occurs as part of the infection mechanism remains to be tested. The study of actin-hijacking mechanisms in pathogens has revealed a great deal about the function of cytoskeletal proteins, and it is possible that identification of YopO-mediated phosphorylation sites on actin-assembly factors in the future will reveal new cytoskeletonregulatory mechanisms in eukaryotes.
Kinase activation then occurs as a three-step process. First, the binding of actin induces a conformational change in the catalytic site. This then leads to phosphorylation of Ser90 and Ser95 in the regulatory loop. Last, this loop is ejected from the catalytic site for full activation of the kinase domain. This is an interesting hypothesis that remains to be tested.
The GDI domain undergoes a substantial conformational change in the complex with actin compared to its structures determined alone or in complex with Rac1 (ref. 13) . When bound to actin, the C-terminal portion of the GDI domain, starting approximately at residue Ala600 (within the so-called 'backbone' helix of the GDI domain 13 ), bends ~30° to close upon actin. A similar, albeit far less pronounced movement, occurs between the free and Rac1-bound structures of the GDI domain, thus suggesting that the backbone helix is prone to bending. Although the GTPase-binding site remains exposed in the complex with actin, and seems mostly unchanged by the interaction, one possibility that remains to be explored is whether the binding of actin allosterically modulates the affinity of GTPases for the GDI domain concurrently with the activation of the kinase domain.
of the immune response has remained elusive. The work by Lee et al. 6 makes several important contributions that substantially advance the understanding of YopO function. First, the structure of YopO in complex with monomeric actin shows that the kinase and GDI domains contribute nearly equally to the interaction with actin, as had been anticipated 11 . Together, these two domains form a pincer-like structure that wraps around actin subdomain 4. Because this interaction interferes with intersubunit contacts in the actin filament, the structure also explains why YopO binds monomeric but not filamentous actin 11 . The interaction with subdomain 4 is rather unusual among actin-binding proteins 18 , and it has been observed only in a complex with another protein from a bacterial pathogen, toxofilin from Toxoplasma gondii 19 . The structure further explains why previous experiments exploring the role of the isolated kinase domain were inconclusive 16 : full activity of the kinase domain requires actin binding, which depends strongly on the presence of the GDI domain.
Lee et al. 6 propose that the autophosphorylation loop (here called the 'regulatory loop') containing Ser90 and Ser95 acts as an autoinhibitory peptide in the absence of actin (Fig. 1) . Figure 1 Mechanism of YopO-mediated cytoskeleton disassembly. A Yersinia cell establishes a first contact with a phagocyte through adhesin-receptor interactions. The bacterium deploys a syringe-like T3SS and injects several effector proteins into the eukaryotic host, including six Yops. YopO is targeted to the plasma membrane via its N-terminal domain, where it interacts with Rho family GTPases through its GDI domain and recruits an actin monomer through interactions with both the GDI and kinase domains. Because Yersinia inject only minute amounts of Yops into target cells in which actin is the most abundant protein, actin-monomer sequestration by YopO is unlikely to have a substantial effect on the eukaryotic cytoskeleton. Instead, YopO disposes of two more efficient strategies to impair the cytoskeleton: downregulation, via its GDI domain, of Rho family GTPases, which control cytoskeleton assembly and sequestration and/or phosphorylation-dependent inactivation of cytoskeleton-assembly factors. These factors include WASP family proteins, which act as nucleation-promoting factors for the Arp2/3 complex; VASP family proteins, which control filament elongation; formins, which control the nucleation and elongation of nonbranched actin networks; and gelsolin, a filament-severing protein. 
